Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA announces that Chief Executive Officer, Tim Wentworth, will present at the 42nd Annual J.P. Morgan Healthcare Conference.

Walgreens Boots Alliance to Participate in 42nd Annual J.P. Morgan Healthcare Conference

Verizon

Keeping it simple is often best when it comes to investing. That's why buying an index fund is often the optimal investment most people can make and paying attention to the highest-yielding dogs of the dow.

3 of the Highest Yielding Dogs of the Dow to Buy for 2024

The pharmacy chain has been struggling with performance and profitability. Walgreens needs to shake up its business, and its new CEO could make a big move.

Where Will Walgreens Boots Alliance Be in 1 Year?

Amgen

Cisco Systems

Chevron

Invesco Dow Jones Industrial Average Dividend ETF

Dow Inc

Goldman Sachs

Coca-Cola

ALPS Sector Dividend Dogs ETF

SPDR Portfolio S&P 500 High Dividend ETF

The Dogs of the Dow in 2023 are up an average of just 2.8%, lagging the market by the widest amount since 2006, per Bespoke Investment Group, as quoted on Investors Business Daily. But more importantly, the Dogs of the Dow trailed the market in four of the past five years, Bespoke found.

Can Dogs of the Dow ETFs Snap Losing Trend in 2024?

Coinbase

VinFast Auto Ltd

Since the end of October, stocks have rallied tremendously, with the S&P 500 soaring 15% and the Russell 2000 jumping 21%. This huge rebound, brought about by greater confidence in the economy and less trepidation about interest rates, resulted in many drastically overvalued stocks.

Short-Sell Candidates: 3 Vastly Overvalued Stocks Ripe for Shorting

Altria

Pfizer

Pioneer Natural Resources

The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women's health under the Premarin family and Eliquis brands Biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands Sterile injectable and anti-infective medicines and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.

5 Dividend Stocks That Could Deliver Life-Changing Returns

Johnson & Johnson

Don't look now. But dividends are back in vogue.

The Dogs of the Dow May Pay Big Dividends in 2024

Alibaba

JPMorgan Chase & Co

Here's a quick economics lesson to return to the good old college days. When markets think that a country's GDP is set to grow in the future, they will turn bullish (massively bullish) toward equity markets.

Quick list of bargain stocks to end the year

AMC Entertainment

Investors looking for solid companies that offer a reliable source of growth may want to avoid the companies I'm listing below. They've all struggled with reduced cash flow, lower-than-expected full-year guidance, and possible bankruptcy.

3 Stocks That Are About to Get Absolutely Crushed

AbbVie

Amcor Plc

Air Products and Chemicals

Franklin Resources

Cincinnati Financial

Essex Property Trust

Federal Realty Investment Trust

Genuine Parts

Hormel Foods

Medtronic

NextEra Energy

Realty Income Corp

PepsiCo

T. Rowe Price Group

Exxon Mobil

"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 66 Aristocrats, screened as of December 12, 2023, represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 13.71%-31.37% topped-by XOM & CVX. By yield, WBA topped-all Aristocrats. Top-ten Yields from ABBV, ESS, CVX, FRT, BEN, TROW, AMCR, O, MMM, & WBA, averaged 5.13%.

5 Dividend Aristocrats Signal Buy In December, With 6 To Watch

Dividend stocks in the S&P 500 and Dow disappointed this year. But analysts think some high yielding Dow stocks are still worth a bet.

5 'Dogs Of The Dow' Stocks Will Pay Off Next Year, Analysts Say

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has everything you need to keep things merry and bright – with convenient in-person and online shopping options to save the day, especially when you need help last-minute. According to a new Walgreens U.S. gift giving trend survey, 83% of Americans found themselves getting a gift for someone at the very last minute—a trend even more common among Gen Z (90%) and parents (92%). To relieve the pressure of last-minute holiday shopping this season, Walgree.

Walgreens Makes it Easy for Customers to Experience Quick, Convenient Holiday Shopping

Walgreens Boots Alliance is dusting down plans on a potential exit from its UK drugstore chain Boots, which could include a listing in London, according to Bloomberg. The Illinois, US-based retailer has been holding early talks about ways to separate Boots, which could be valued at about £7 billion, Bloomberg said, citing people with knowledge of the deal.

Walgreens revives Boots exit plan in deal that could boost London

Walgreens Boots Alliance may sell its Boots pharmacies in the United Kingdom as the company's new chief executive officer reviews the U.S. drugstore chain's businesses and faces a more urgent need to cut debt.

Once Again, Walgreens May Try To Unload UK Boots Drugstores

Walgreens Boots Alliance Inc (NASDAQ:WBA) is exploring the spinoff of its UK-based Boots drugstore chain with an eye on an IPO in the country, according to a report from Bloomberg News.  The chain could be worth $8.78 billion, according to sources familiar with the matter.

Walgreens considers spinoff and IPO of Boots pharmacy chain

Dollar General

DISH Network

It's the end of the year, which means it is “tax loss harvesting” time. Specifically, investors sell losing positions to offset capital gains taxes from stocks they sold that earned them a profit.

3 Useless Stocks to Sell in 2023 to Reduce Your Taxes in 2024

Walgreens Boots Alliance is in early talks over ways to separate the UK-based Boots drugstore chain, including the possibility of a initial public offering in London, according to a Bloomberg News report on Tuesday.

Walgreens mulls IPO for UK Boots pharmacy chain - Bloomberg News

Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.

Walgreens' (WBA) AllianceRx Pharmacy Will Now Distribute XDEMVY

Walgreens' business demonstrated solid revenue growth over the last decade, but profitability metrics are shrinking, which raises concerns over the dividend safety. I consider dividend cut risk to be remote, but even if this is the case, the saved funds will be reallocated to deleverage the balance sheet and improve investors' sentiment. My valuation analysis suggests WBA stock is massively undervalued, but it might take several quarters before the gap between the fair value and the stock price narrows.

Walgreens: The 9.4% Dividend Yield Is Too High To Ignore

A short squeeze may be on at Walgreens Boots Alliance. The stock climbing today doesn't negate the challenges facing the industry today.

Why Walgreens Boots Alliance Shares Jumped 8.8% Today

Walgreens Boots Alliance Inc.'s stock WBA, +8.33% rose 8% Thursday to lead Dow Jones Industrial Average DJIA, +0.19% and S&P 500 SPX, +0.75% gainers. The stock remains down 38% in the year to date, which is putting it on track for its worst year on record, according to Dow Jones Market Data, based on data going back to January of 1972.

Walgreens' stock soars 8% to lead DJIA and S&P 500 gainers, but is still on track for worst year since 1972

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2024 first quarter results at 7 a.m. ET on Thursday, January 4, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. The replay will also be available from a.

Walgreens Boots Alliance Schedules Fiscal 2024 First Quarter Earnings Announcement for January 4

Boston Properties

Devon Energy

Invesco

KeyCorp

Kinder Morgan

Healthpeak Properties

AT&T

Truist Financial

Whirlpool

There's nothing like a plunge in yields to 4.1% to cool the dash to buy 10-year Treasuries. Now you can buy S&P 500 stocks that yield more.

13 S&P 500 Dividend Stocks Pay 50% More Than 10-Year Treasuries

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is offering flu and COVID-19 testing appointments nationwide as the U.S. heads into the holidays and the winter months that typically coincide with peak respiratory illness season.1,2 Individuals can visit Walgreens.com/Testing, use the Walgreens app to schedule an appointment. Walgreens also provides various in-store and at-home testing and treatment options to help everyone stay healthy and feel better faster if they are experiencing symptoms. “Resp.

Walgreens Announces Expanded COVID-19 and Flu Testing and Treatment Offerings

CVS Health

Premier

Select Medical Holdings

With the equities sector falling flat while the cryptocurrency arena skyrockets, the difficulties associated with planning next moves help drive the bullish case for dividend-paying healthcare stocks. As a defensive play, the broader wellness ecosystem should instill confidence.

News for Walgreens Stock (WBA)